3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Adamantiades-Behcet Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantarini, L; Capecchi, PL; Castrichini, M; Franceschini, R; Galeazzi, M; Gamberucci, A; Gianchecchi, E; Hammoud, M; Laghi-Pasini, F; Lazzerini, PE; Montilli, C; Moramarco, A; Natale, M; Ricci, G; Selvi, E; Zimbone, S | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Adamantiades-Behcet Disease
Article | Year |
---|---|
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α.
Topics: Adenosine Triphosphate; Adult; Behcet Syndrome; Biological Transport, Active; Calcium; Cells, Cultured; Female; Gene Expression Regulation; Humans; Immunity, Innate; Interleukin-1beta; Ion Transport; Lipopolysaccharides; Macrophages; Male; Monocytes; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Agonists; Receptors, Purinergic P2X7; Tumor Necrosis Factor-alpha | 2014 |